Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2012
11/28/2012CN102293755B Two lyophilized powder injections of methylprednisolone sodium succinate and preparation methods thereof
11/28/2012CN102293754B Methylprednisolone sodium succinate freeze-dried powder injection and preparation method thereof
11/28/2012CN102284062B Capsule shell composition for soft capsule containing ciclosporin, preparation method thereof and soft capsule containing ciclosporin prepared thereby
11/28/2012CN102258588B Preparation method of peony general glycoside
11/28/2012CN102212447B Health-care wine
11/28/2012CN102153548B Analogue nucleoside derivative containing thiazolidone (thiazinidone) ring, preparation method and application thereof to medicinal preparations
11/28/2012CN102145013B Method for preparing liposome solution of chicken spleen transfer factor
11/28/2012CN102002045B Pyrazolopyrimidinone derivatives as well as preparation method and application thereof
11/28/2012CN101862456B Remedy
11/28/2012CN101827841B (R)-4-(heteroaryl) phenylethyl derivatives and pharmaceutical compositions containing them
11/28/2012CN101696183B (Z)-2-phenyl-3-(pyrrol-2-yl)-acrylonitrile derivative as well as salts, composition, preparation method and application thereof
11/28/2012CN101478978B Delta-tocotrienol treatment and prevention of pancreatic cancer
11/28/2012CN101279955B N-substituted thiamorpholine derivate as DPP-IV inhibitor and medical use thereof
11/28/2012CN101172125B Ganoderma lucidum liquid fermentate, composition containing the fermentate , preparation method and application of the same
11/27/2012US8318910 IL-13 receptor antibodies
11/27/2012US8318782 Mitotic kinesin inhibitor
11/27/2012US8318769 Substituted sulfonamide compounds
11/27/2012US8318764 Macrocyclic inhibitors of JAK
11/27/2012US8318709 Combination of azelastine and mometasone for nasal administration
11/27/2012US8318467 Inhibitors of GSK-3 and crystal structures of GSK-3β protein and protein complexes
11/27/2012US8318173 for treating a patient with cancer comprising a cancer-specific antigen or a nucleic acid encoding the protein to the patient; genetic engineering; drug delivery; kits
11/27/2012CA2658221C Anti-cd40 monoclonal antibody
11/27/2012CA2533377C Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
11/27/2012CA2531505C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-vitamin d3 and its uses
11/27/2012CA2516702C Modified t cell receptor linked by disulphide bond between constant domain cysteine residues
11/27/2012CA2451051C Siglec inhibitors
11/27/2012CA2432525C Streptococcus pyogenes antigens and corresponding dna fragments
11/27/2012CA2347131C Modified peptides as therapeutic agents
11/27/2012CA2325605C Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein said peptides bind to mhc class i and mhc class ii molecules, and uses thereof
11/27/2012CA2181832C Immunization by inoculation of dna transcription unit
11/22/2012WO2012159100A1 Il-12 p40 monomer, monoclonal antibody against p40 homodimer and the combination of the two for autoimmune disease treatment
11/22/2012WO2012158529A2 Compositions and methods for immunization against drug resistant acinetobacter baumannii
11/22/2012WO2012158002A1 Medicinal preparation "renessans" having an antibacterial, anti-ulcerous and immuno-modulating action
11/22/2012WO2012157752A1 Pharmaceutical composition containing loxoprofen
11/22/2012WO2012157746A1 Therapeutic drug for autoimmune disease
11/22/2012WO2012157737A1 Immunity inducing agent
11/22/2012WO2012157736A1 Immunity induction agent
11/22/2012WO2012157721A1 Liposome containing pyrroloquinoline quinone and sugar
11/22/2012WO2012157699A1 Immunostimulant for animals, feed containing same, and method for manufacturing same
11/22/2012WO2012157479A1 Ctrp6 which can be used as therapeutic and prophylactic agent for autoimmune diseases
11/22/2012WO2012157389A1 Low-molecular-weight compound capable of regulating rac activation induced by dock-a subfamily molecule, and use thereof
11/22/2012WO2012156936A1 Substituted indole derivatives for the treatment of immunological disorders
11/22/2012WO2012156522A1 Cell populations having immunoregulatory activity, methods for the preparation and uses thereof
11/22/2012WO2012156467A1 Novel pkc inhibitors
11/22/2012WO2012156334A1 Inhibitors of bruton's tyrosine kinase
11/22/2012WO2012156219A1 Amino acid sequences directed against il-17a, il-17f and/or il17-a/f and polypeptides comprising the same
11/22/2012WO2012155262A1 Virus-like particles and process for preparing same
11/22/2012WO2012155199A1 Amine derivatives as potassium channel blockers
11/22/2012WO2012142237A8 Fused imidazole derivatives useful as ido inhibitors
11/22/2012WO2012125720A3 Polypeptides having immunoactivating activity and methods of producing the same
11/22/2012WO2012108960A3 Ghrelin mimetic polypeptide hapten immunoconjugates having improved solubility and immunogenicity and methods of use thereof
11/22/2012US20120296403 Methods and compounds for muscle growth
11/22/2012US20120296072 N-terminally chemically modified protein compositions and methods
11/22/2012US20120295956 Prevention of tissue ischemia and related methods
11/22/2012US20120295954 Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
11/22/2012US20120295952 Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
11/22/2012US20120295947 Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
11/22/2012US20120295933 Treatment of copd, gastro-esophageal reflux disease (gerd), food allergies and other gastrointestinal conditions and disorders ameliorated by proper histamine management using a combination of histidine decarboxylase inhibators, lra drugs, anti-h1 and/or anti-h2 drugs
11/22/2012US20120295912 Piperazinylpiperidine derivatives as chemokine receptor antagonists
11/22/2012US20120295909 Alkyl-heterocycle carbamate derivatives, their preparation and their therapeutic application
11/22/2012US20120295900 1,3-oxazines as bace 1 and/or bace2 inhibitors
11/22/2012US20120295899 Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity
11/22/2012US20120295896 Oxadiazole inhibitors of leukotriene production
11/22/2012US20120295885 Inhibitors of bruton's tyrosine kinase
11/22/2012US20120295884 Complement pathway modulators and uses thereof
11/22/2012US20120295877 Therapeutic Compounds
11/22/2012US20120295856 Fredericamycin derivatives
11/22/2012US20120295845 Imidazo-pyrazoles as gpr119 inhibitors
11/22/2012US20120295835 Sgef controls macular, corpus callosum and hippocampal function and development, liver homeostasis, functions of the immune system, fever response atherosclerosis and tumorogenic cell growth
11/22/2012US20120294946 Modulator
11/22/2012US20120294939 Direct compression formulation and process
11/22/2012US20120294930 Combination of kinase inhibitors and uses thereof
11/22/2012US20120294901 Novel cochleate formulations
11/22/2012US20120294896 Methods and Compositions for Poxvirus A35R Protein
11/22/2012US20120294895 Protein a compositions and methods of use
11/22/2012US20120294894 Pharmaceutical composition and method for producing the same
11/22/2012US20120294893 Edible jelly-form composition, jelly-form preparation and method for producing jelly-form preparation
11/22/2012US20120294892 Avirulent Salmonella Gallinarum Variants and Pharmaceutical Composition Using the Same
11/22/2012US20120294891 Materials and methods for detecting, preventing, and treating retroviral infection
11/22/2012US20120294890 Recombinant Parainfluenza Virus Expression Systems And Vaccines
11/22/2012US20120294888 Tolerogenic synthetic nanocarriers for allergy therapy
11/22/2012US20120294886 Peptide conjugates for suppressing an immune response, methods of making and uses therefor
11/22/2012US20120294884 Methods of blocking tissue destruction by autoreactive t cells
11/22/2012US20120294883 Oligomeric receptor ligand pair member complexes
11/22/2012US20120294881 Peptides protective against s. pneumoniae and compositions, methods and uses relating thereto
11/22/2012US20120294880 Novel immunogenic compositions for the prevention and treatment of meningococcal disease
11/22/2012US20120294877 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
11/22/2012US20120294876 Vaccine and health-related applications for ruminant breath monitoring system
11/22/2012US20120294863 Anti-CD70 Antibody and Its Use for the Treatment and Prevention of Cancer and Immune Disorders
11/22/2012US20120294862 Antagonists of il-17a, il-17f, and il-23p19
11/22/2012US20120294851 Cancer Therapies and Pharmaceutical Compositions Used Therein
11/22/2012US20120294850 Ganglioside Epitopes For Treating Guillain-Barre Syndrome
11/22/2012US20120294849 Use of wf10 for treating allergic asthma, allergic rhinitis and atopic dermatitis
11/22/2012US20120294848 IGE CH3 Peptide Vaccine
11/22/2012US20120294838 Regulation of endogenous gene expression in cells using zinc finger proteins
11/22/2012US20120294831 Use of thiazolide compounds for the prevention and treatment of viral diseases, cancer and diseases caused by intracellular infections
11/22/2012US20120294802 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers
11/22/2012US20120294798 Methods of treating cancer using il-21
11/22/2012US20120294797 Anti-cgrp compositions and use thereof
11/22/2012CA2836568A1 Immunity induction agent
1 ... 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 ... 1172